Cargando…
Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231493/ https://www.ncbi.nlm.nih.gov/pubmed/32425287 http://dx.doi.org/10.1016/j.jhin.2020.05.020 |
_version_ | 1783535202236104704 |
---|---|
author | Donà, D. Di Chiara, C. Sharland, M. |
author_facet | Donà, D. Di Chiara, C. Sharland, M. |
author_sort | Donà, D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7231493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Healthcare Infection Society. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72314932020-05-18 Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact Donà, D. Di Chiara, C. Sharland, M. J Hosp Infect Article The Healthcare Infection Society. Published by Elsevier Ltd. 2020-09 2020-05-17 /pmc/articles/PMC7231493/ /pubmed/32425287 http://dx.doi.org/10.1016/j.jhin.2020.05.020 Text en © 2020 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Donà, D. Di Chiara, C. Sharland, M. Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title | Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title_full | Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title_fullStr | Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title_full_unstemmed | Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title_short | Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact |
title_sort | multi-drug-resistant infections in the covid-19 era: a framework for considering the potential impact |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231493/ https://www.ncbi.nlm.nih.gov/pubmed/32425287 http://dx.doi.org/10.1016/j.jhin.2020.05.020 |
work_keys_str_mv | AT donad multidrugresistantinfectionsinthecovid19eraaframeworkforconsideringthepotentialimpact AT dichiarac multidrugresistantinfectionsinthecovid19eraaframeworkforconsideringthepotentialimpact AT sharlandm multidrugresistantinfectionsinthecovid19eraaframeworkforconsideringthepotentialimpact |